Product Information
GNP MUCUS ER 600 MG TABLET is a generic product labeled by AmerisourceBergen, priced at $0.2840 per EA under NDC 46122075051. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on Jul 16, 2018.
Strength
600 mg/1
Manufacturer
AmerisourceBergenNDC
46122075051
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA209254FDA Approved
7/16/2018
On Market Since
8/11/2023
Pharmacological Classes
Price Statistics
The NADAC for GNP MUCUS ER 600 MG TABLET has been published 147 times since Dec 13, 2023, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2840 per EA |
|---|---|
| All-time high | $0.3993 (Dec 11, 2024) |
| All-time low | $0.2840 (Sep 23, 2026) |
| 52-week high | $0.3211 |
| 52-week low | $0.2840 |
| Median price | $0.3211 |
| Average price | $0.3236 |
| Largest weekly change | +24.7% (Nov 20, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP MUCUS ER 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GNP MUCUS ER 600 MG TABLET, manufactured by AmerisourceBergen, is $0.2840 per EA (NDC 46122075051), effective Sep 30, 2026.
How has the price of GNP MUCUS ER 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GNP MUCUS ER 600 MG TABLET has declined 9.9%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for GNP MUCUS ER 600 MG TABLET?
Since Dec 13, 2023, the NADAC for GNP MUCUS ER 600 MG TABLET has ranged from a low of $0.2840 (Sep 23, 2026) to a high of $0.3993 (Dec 11, 2024), with a median of $0.3211 per EA.
Are there cheaper alternatives to GNP MUCUS ER 600 MG TABLET?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP MUCUS ER 600 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP MUCUS ER 600 MG TABLET?
GNP MUCUS ER 600 MG TABLET (NDC 46122075051) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.